N. V. Marques

Machine learning-based prediction model for treatment of acromegaly with first-generation somatostatin receptor ligands.

J. Abucham, L. Kasuki, M. Gadelha, 2021, The Journal of clinical endocrinology and metabolism.

Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy

L. Kasuki, M. Gadelha, E. Gasparetto, 2015, Clinical endocrinology.

ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas

L. Kasuki, M. Gadelha, E. Gasparetto, 2013, PloS one.

Acromegalic patients lost to follow-up: a pilot study

L. Kasuki, M. Gadelha, V. L. Leal, 2013, Pituitary.

Frequency of familial pituitary adenoma syndromes among patients with functioning pituitary adenomas in a reference outpatient clinic

L. Kasuki, M. Gadelha, L. E. Wildemberg, 2017, Journal of Endocrinological Investigation.

Correction: ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas

L. Kasuki, M. Gadelha, E. Gasparetto, 2013, PLoS ONE.

Long-term efficacy and safety of pasireotide in patients with acromegaly: 14 years' single-center real-world experience.

M. Gadelha, L. E. Wildemberg, N. V. Marques, 2023, The Journal of clinical endocrinology and metabolism.